Methotrexate-induced transient encephalopathy in an adolescent and young adult patient with acute lymphoblastic Leukemia

1Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

A 17-year-old girl was diagnosed with acute lymphoblastic leukemia (ALL). After the administration of high-dose methotrexate (MTX) or intrathecal MTX, the patient experienced transient hemiparesis and motor aphasia. Diffusion-weighted magnetic resonance imaging showed a high-intensity lesion in the bilateral centrum semiovale, and a vasospasm was detected in the proximal segment of bilateral A1 on magnetic resonance angiography. Edaravone was administered, and leucovorin rescue treatment was continued; eventually, the patient’s neurological symptoms completely resolved. This finding suggested that vasospasm might be a mechanism underlying MTX-induced transient encephalopathy in adolescent and young adult patients with ALL.

Cite

CITATION STYLE

APA

Teshima, K., Kume, M., Kondo, R., Shibata, K., Abe, K., Aono, H., … Takahashi, N. (2021). Methotrexate-induced transient encephalopathy in an adolescent and young adult patient with acute lymphoblastic Leukemia. Internal Medicine, 60(13), 2115–2118. https://doi.org/10.2169/internalmedicine.5937-20

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free